P21-Activated Kinase 4 Promotes Intimal Hyperplasia and Vascular Smooth Muscle Cells Proliferation During Superficial Femoral Artery Restenosis After Angioplasty
Overview
Biotechnology
General Medicine
Authors
Affiliations
The aim of this study is to explore the function of p21-activated kinase 4 (PAK4) in intimal hyperplasia (IH) and vascular smooth muscle cells (VSMCs) proliferation. We choose vascular samples from patients undergoing angioplasty in superficial femoral artery (SFA) as the experimental group and vascular samples from donors without clinical SFA restenosis as the control group, respectively. We draw from the results that both levels of mRNA and protein of PAK4 in the experimental group increased dramatically compared with the control group. IH arose from angioplasty of SFA. Moreover, overexpression of PAK4 dramatically contributed to cell proliferation of VSMCs and promoted cell cycle progression from G0/G1 phase (71.12 ± 0.69% versus 58.77 ± 0.77%, < 0.001) into S phase (23.99 ± 0.21% versus 31.35 ± 0.33%, < 0.001). Besides, PAK4 downregulated the level of p21 and enhanced the activity of Akt as well. And we conclude that PAK4 acts as a regulator of cell cycle progression of VSMC by mediating Akt signaling and controlling p21 levels, which further modulate IH and VSMCs' proliferation.
PAK in Pancreatic Cancer-Associated Vasculature: Implications for Therapeutic Response.
Ansardamavandi A, Nikfarjam M, He H Cells. 2023; 12(23).
PMID: 38067120 PMC: 10705971. DOI: 10.3390/cells12232692.
Zhong C, Ju G, Yang S, Zhao X, Chen J, Li N Gynecol Obstet Invest. 2023; 88(4):197-213.
PMID: 36934719 PMC: 10619591. DOI: 10.1159/000530104.
Su K, Hao W, Lv Z, Wu M, Li J, Hu Y Front Neurol. 2022; 13:855362.
PMID: 36062010 PMC: 9437581. DOI: 10.3389/fneur.2022.855362.
The Use of Nanomedicine to Target Signaling by the PAK Kinases for Disease Treatment.
Wang Y, Minden A Cells. 2021; 10(12).
PMID: 34944073 PMC: 8700304. DOI: 10.3390/cells10123565.
Zhao X, Huang J, Mo Z, Wei J, Zhong C, Teng H Biomed Res Int. 2021; 2021:6682525.
PMID: 34337044 PMC: 8292040. DOI: 10.1155/2021/6682525.